Substance / Medication

Oxacillin

Overview

Active Ingredient
oxacillin
RxNorm CUI
7773

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

135 trials linked to this intervention

135
Total Trials
28
Recruiting
20
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Charting the global footprint of borderline oxacillin-resistant(BORSA): the first systematic review and meta-analysis.
Engku Abd Rahman Engku Nur Syafirah, Irekeola Ahmad Adebayo, Yamin Dina et al. · PeerJ · 2024
PMID: 39703916Meta-AnalysisFull text (PMC)
A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients.
Wallenburg Eveline, Brüggemann Roger J M, Roberts Jason A et al. · Clin Microbiol Infect · 2022
PMID: 34245903Meta-Analysis
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes.
Iversen Ditte B, Dunvald Ann-Cathrine Dalgård, Jespersen Daniel M et al. · Clin Pharmacol Ther · 2023
PMID: 37235733RCT
A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin duringBone and Joint Infections.
Courjon Johan, Garzaro Margaux, Roger Pierre-Marie et al. · Antimicrob Agents Chemother · 2020
PMID: 32988822RCTFull text (PMC)
Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.
Stage Tore Bjerregaard, Graff Magnus, Wong Susan et al. · Br J Clin Pharmacol · 2018
PMID: 29105855RCTFull text (PMC)
Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu Guolan, Zheng Yunliang, Zhou Huili et al. · Drug Des Devel Ther · 2015
PMID: 26527863RCTFull text (PMC)
Effect of maternal skin-to-skin contact on decolonization of Methicillin-Oxacillin-Resistant Staphylococcus in neonatal intensive care units: a randomized controlled trial.
Lamy Filho Fernando, de Sousa Sílvia Helena Cavalcante, Freitas Isolina Januária Sousa et al. · BMC Pregnancy Childbirth · 2015
PMID: 25880822RCTFull text (PMC)
A randomized prospective study of prophylactic cloxacillin in breast reduction surgery.
Lewin Richard, Elander Anna, Thorarinsson Andri et al. · Ann Plast Surg · 2015
PMID: 25305230RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oxacillin (substance)
SNOMED CT
372868007
UMLS CUI
C0029983
RxNorm CUI
7773

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

11
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
135
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.